Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2025-12-25 @ 2:34 AM
NCT ID:
NCT00002234
Eligibility Criteria:
Inclusion Criteria
You may be eligible for this study if you:
* Are HIV-positive.
* Are at least 13 years old (need consent of parent or guardian if under 18).
* Have an HIV count of 5,000 copies/ml or more within 30 days prior to study entry.
* Have a CD4+ count of 50 cells/mm3 or more.
Exclusion Criteria
You will not be eligible for this study if you:
* Are diagnosed with hepatitis within 30 days prior to study entry.
* Have certain serious medical conditions, including an AIDS-defining clinical condition.
* Received chemotherapy or radiation therapy within 30 days of study entry.
* Have taken any nucleoside reverse transcriptase inhibitors (NRTIs) for more than 2 weeks.
* Have ever taken 3TC.
* Have ever taken any non-nucleoside reverse transcriptase inhibitors (NNRTIs).
* Have taken medications that affect your immune system within 30 days prior to study entry.
* Have received a vaccine within 30 days prior to study entry.
* Are enrolled in another anti-HIV drug study while participating in this study.
* Abuse alcohol or drugs.
* Are pregnant or breast-feeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
13 Years
Study:
NCT00002234
Study Brief:
Protocol Section:
NCT00002234